Suivre
Pierre-Louis Toutain
Titre
Citée par
Citée par
Année
The pharmacokinetic–pharmacodynamic approach to a rational dosage regimen for antibiotics
PL Toutain, JRE Del Castillo, A Bousquet-Mélou
Research in veterinary science 73 (2), 105-114, 2002
4552002
Plasma terminal half‐life
PL Toutain, A Bousquet‐mélou
Journal of veterinary pharmacology and therapeutics 27 (6), 427-439, 2004
3862004
Pharmacodynamics and pharmacokinetics of nonsteroidal anti‐inflammatory drugs in species of veterinary interest
P Lees, MF Landoni, J Giraudel, PL Toutain
Journal of veterinary pharmacology and therapeutics 27 (6), 479-490, 2004
3862004
Plasma clearance
PL Toutain, A Bousquet‐mélou
Journal of veterinary pharmacology and therapeutics 27 (6), 415-425, 2004
3362004
Similarity of bisphenol A pharmacokinetics in rhesus monkeys and mice: relevance for human exposure
JA Taylor, FS Vom Saal, WV Welshons, B Drury, G Rottinghaus, PA Hunt, ...
Environmental health perspectives 119 (4), 422-430, 2011
3222011
Bioavailability and its assessment
PL Toutain, A Bousquet‐mélou
Journal of veterinary pharmacology and therapeutics 27 (6), 455-466, 2004
3222004
Species differences in pharmacokinetics and pharmacodynamics
PL Toutain, A Ferran, A Bousquet-Mélou
Comparative and veterinary pharmacology, 19-48, 2010
2782010
Volumes of distribution
PL Toutain, A Bousquet‐mélou
Journal of veterinary pharmacology and therapeutics 27 (6), 441-453, 2004
2762004
Integration and modelling of pharmacokinetic and pharmacodynamic data to optimize dosage regimens in veterinary medicine
PL Toutain, P Lees
Journal of veterinary pharmacology and therapeutics 27 (6), 467-477, 2004
2542004
Holding thermal receipt paper and eating food after using hand sanitizer results in high serum bioactive and urine total levels of bisphenol A (BPA)
AM Hormann, FS Vom Saal, SC Nagel, RW Stahlhut, CL Moyer, ...
PloS one 9 (10), e110509, 2014
2332014
The pharmacokinetics of xylazine hydrochloride: an interspecific study
R GARCIA‐VILLAR, PL Toutain, M Alvinerie, Y Ruckebusch
Journal of veterinary pharmacology and therapeutics 4 (2), 87-92, 1981
2101981
Plasma exogenous creatinine clearance test in dogs: comparison with other methods and proposed limited sampling strategy
ADJ Watson, HP Lefebvre, D Concordet, V Laroute, JP Ferré, JP Braun, ...
Journal of Veterinary Internal Medicine 16 (1), 22-33, 2002
1802002
Creatine kinase in the dog: a review
M Aktas, D Auguste, HP Lefebvre, PL Toutain, JP Braun
Veterinary research communications 17, 353-369, 1993
1631993
Comparative pharmacokinetics of doramectin and ivermectin in cattle
PL Toutain, DW Upson, TN Terhune, ME McKenzie
Veterinary Parasitology 72 (1), 3-8, 1997
1591997
En route towards European clinical breakpoints for veterinary antimicrobial susceptibility testing: a position paper explaining the VetCAST approach
PL Toutain, A Bousquet-Mélou, P Damborg, AA Ferran, D Mevius, ...
Frontiers in microbiology 8, 314351, 2017
1442017
High bioavailability of bisphenol A from sublingual exposure
V Gayrard, MZ Lacroix, SH Collet, C Viguié, A Bousquet-Melou, ...
Environmental health perspectives 121 (8), 951-956, 2013
1402013
Plasma concentrations and therapeutic efficacy of phenylbutazone and flunixin meglumine in the horse: pharmacokinetic/pharmacodynamic modelling
PL Toutain, A Autefage, C Legrand, M Alvinerie
Journal of veterinary pharmacology and therapeutics 17 (6), 459-469, 1994
1401994
Comparison of pharmacokinetic profiles of doramectin and ivermectin pour-on formulations in cattle
V Gayrard, M Alvinerie, PL Toutain
Veterinary Parasitology 81 (1), 47-55, 1999
1381999
Should oral gavage be abandoned in toxicity testing of endocrine disruptors?
LN Vandenberg, WV Welshons, FS Vom Saal, PL Toutain, JP Myers
Environmental Health 13, 1-7, 2014
1362014
Free drug fraction vs. free drug concentration: a matter of frequent confusion
PL Toutain, A Bousquet‐Mélou
Journal of veterinary pharmacology and therapeutics 25 (6), 460-463, 2002
1362002
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20